-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$7.00442.64% Upside
SELLAS Life Sciences Group, Inc. Frequently Asked Questions
-
What analysts cover SELLAS Life Sciences Group, Inc.?
SELLAS Life Sciences Group, Inc. has been rated by research analysts at Industrial Alliance Securities, Cantor Fitzgerald in the past 90 days.